SCHEMBL6162257

SCHEMBL6162257

c1ccc(COc2cc(OCc3ccccc3)cc(-c3nnc(Nc4cccc(SCc5ccccc5-c5ccccc5)c4)s3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
KMT2A Q03164 7/20 0.38
MEN1 O00255 5/20 0.38
MAPT P10636 4/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.38
SAE1 Q9UBE0 1/20 0.38
UBA2 Q9UBT2 1/20 0.38
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
ALDH1A1 P00352 4/20 0.37
PTGER4 P35408 2/20 0.36
PTGER3 P43115 2/20 0.36
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36
RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155082 0.83 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBKMT2AMEN1
SCHEMBL5557652 0.80 MRGPRX4 (0.43) KMT2AMEN1LMNAALDH1A1ROCK2
SCHEMBL5557342 0.79 KMT2A (0.47) KMT2AMEN1MAPTNPSR1LMNA
SCHEMBL6155089 0.79 PIK3CD (0.48) PIK3CDPIK3CAPIK3CBKMT2AMEN1
SCHEMBL5558769 0.79 MAPT (0.46) KMT2AMEN1MAPTNPSR1LMNA
SCHEMBL5552796 0.78 MAPT (0.42) KMT2AMEN1MAPTNPSR1LMNA
SCHEMBL6156893 0.78 KMT2A (0.40) PIK3CDPIK3CAPIK3CBKMT2AMEN1
SCHEMBL6154208 0.77 HDAC6 (0.40) PIK3CDPIK3CAPIK3CBKMT2AMEN1
SCHEMBL6154206 0.77 HDAC6 (0.40) PIK3CDPIK3CAPIK3CBKMT2AMEN1
Ammonia Solution, Strong SCHEMBL6155214 0.77 HDAC6 (0.40) PIK3CDPIK3CAPIK3CBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP PIK3CD 2104/4885PIK3CA 2270/4885PIK3CB 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.